Key takeaways:
Ozempic and Wegovy are both semaglutide injections. Ozempic is approved to treat Type 2 diabetes in adults. Wegovy is a higher-dose version that’s approved for weight loss. They aren’t interchangeable.
Adults and adolescents ages 12 and older with a larger body size may be eligible for Wegovy. People with Type 2 diabetes can also use Wegovy, but it’s not approved to treat diabetes.
The recommended Wegovy maintenance dosage is 2.4 mg once weekly. If you can’t tolerate this dosage, you may stick with 1.7 mg weekly instead. The maximum Ozempic dosage is 2 mg once weekly.
There are ways to save on Wegovy and Ozempic, which are available as brand-name medications. Manufacturer copay cards and GoodRx discounts can help make your prescription more affordable.
Wegovy and Ozempic are once-weekly injections that contain the same active ingredient: semaglutide. These injectable medications have been gaining a lot of attention recently and, in fact, were both previously in shortage due to increased demand. But they aren’t exactly the same, and they’re not considered to be interchangeable.
Below, we review five differences between Wegovy and Ozempic that you should know about.
Even though they both contain semaglutide, Wegovy and Ozempic were studied for different reasons during clinical trials. Wegovy trials were focused on weight loss. Ozempic trials were focused on Type 2 diabetes and its complications. The results of these trials were used to support each medication’s approved uses.
Wegovy approved uses | Ozempic approved uses |
---|---|
|
|
Wegovy and Ozempic work the same way in the body by mimicking the effects of a natural hormone called glucagon-like peptide-1 (GLP-1). But you may be prescribed Wegovy or Ozempic for different reasons. In either case, a healthy diet and regular exercise are key to getting the best results with both.
Save every month on GLP-1 meds with GoodRx
Save an average of $235 on FDA-approved GLP-1s like Ozempic and Zepbound.
As covered above, Wegovy and Ozempic have different approved uses. This also means that eligibility criteria can vary depending on your health history and treatment goals.
You may be eligible for Wegovy if you’re:
An adult or adolescent considered to be obese
An adult considered to be overweight and you have heart disease or at least one weight-related health condition (such as high blood pressure or Type 2 diabetes)
You may be eligible for Ozempic if you’re an adult with Type 2 diabetes. If you’re prescribed Ozempic for weight loss but don’t have diabetes, this is considered an off-label use.
Not exactly. Wegovy isn’t approved for diabetes. But if you have Type 2 diabetes, you may be eligible for Wegovy. Because of how it works, you may see some blood sugar (glucose) benefits while using it. And healthy weight loss can have positive effects on your blood sugar levels, too. Your prescriber may decide it’s right for you as part of your weight-management plan.
Wegovy and Ozempic are both once-weekly injections, and they share the same starting dose. But their dosage schedules and long-term target doses are different. Wegovy is gradually increased to a higher target dose for weight loss. Ozempic, on the other hand, is slowly increased to lower doses for diabetes or kidney protection.
Typical Wegovy dosage schedule | Typical Ozempic dosage schedule |
---|---|
|
|
Wegovy and Ozempic both come as injection pens, but they don’t work the same way. Wegovy comes in a single-dose prefilled pen that you’ll throw away after injecting your dose. The Ozempic pen contains multiple doses, and you’ll need to dial up your specific dose each time you inject.
How to save: Glucagon-like peptide-1 (GLP-1) medications such as Ozempic and Wegovy don’t need to break the bank. Explore ways to save on your prescription with this GLP-1 savings guide.
Semaglutide side effects: Are you feeling nauseated after starting Ozempic or Wegovy? Learn more about potential semaglutide side effects and how to manage them.
Foods to avoid: Learn more about foods that can worsen Ozempic side effects, plus a few foods to consider adding to your diet.
Wegovy and Ozempic don’t work overnight. It can take several weeks or months to see their benefits, depending on the reason you’re using them.
If you’re using Wegovy for weight loss, many people begin to notice changes in their appetite shortly after starting treatment. Modest weight loss may begin within the first month. But most weight loss tends to occur within the first 20 weeks (5 months). During clinical trials, adults lost an average of about 10% of their starting body weight during this time.
For Ozempic, the starting dose (0.25 mg) isn’t meant to have a significant effect on your blood sugar levels. Instead, it helps your body adjust to the medication. Most people start seeing blood sugar improvements after the first month. Your dosage may be increased after that to help you reach your treatment goals.
Wegovy is prescribed at a higher dose (up to 2.4 mg weekly) than Ozempic (typically up to 2 mg weekly). Side effects are slightly more likely with higher doses, so they may be more common with Wegovy.
Both medications are known to cause gastrointestinal side effects, especially when starting treatment or after increasing your dose. These include:
Vomiting
Stomach pain
To help minimize side effects, both Wegovy and Ozempic are started at a low dose, which is gradually increased over time. This helps your body adjust to the medication.
Wegovy and Ozempic may be covered differently under your insurance plan. Ozempic is typically covered if you have Type 2 diabetes. Wegovy, on the other hand, may not be covered for weight loss alone. But it may be covered if you have a larger body size and heart disease. It’s best to check with your plan ahead of time for specific coverage details.
Ozempic and Wegovy are not technically considered interchangeable. So you typically won’t switch from one to the other. This is especially true if you’re taking Ozempic for Type 2 diabetes, since Wegovy isn’t approved for that use.
That said, sometimes Ozempic is prescribed off-label for weight loss. In this case, your prescriber might decide to switch you from Ozempic to Wegovy.
Since Wegovy is available in a higher maximum dose compared to Ozempic, it’s possible that it may result in greater weight loss. However, the highest Wegovy and Ozempic doses — 2.4 mg and 2 mg — haven’t been compared directly in studies. So we don’t know for sure if this difference results in significantly more weight loss.
During clinical trials, adults taking Wegovy lost nearly 15% of their starting body weight on average after 68 weeks (almost 16 months). In a separate trial, adolescents lost about 16% of their starting body mass index (BMI) on average.
There are ways to save on Wegovy and Ozempic, which are available as brand-name medications. Manufacturer copay cards, patient assistance programs, and direct options can help make your prescription more affordable.
Manufacturer copay cards: If you have commercial insurance, you could pay as little as $0 for Wegovy and $25 for Ozempic with a copay savings card.
NovoCare pharmacy: If you’re uninsured, or if your plan doesn’t cover Wegovy, you could pay $499 per month for Wegovy through NovoCare Pharmacy.
Patient assistance program: If you’re eligible, you could get Ozempic at no cost through a patient assistance program offered by the manufacturer.
It depends. Actual costs can vary depending on your insurance coverage and if you’re eligible for a copay savings card, patient assistance program, or other ways to save.
Wegovy is specifically designed and studied for weight loss, using a higher dose of semaglutide than Ozempic. As a result, you may lose more weight — and lose it faster — with Wegovy.
Wegovy and Ozempic are both injections that contain semaglutide. But they have a few notable differences, including their approved uses, dosages, and how they’re covered by insurance.
Wegovy is specifically approved for weight loss, while Ozempic is approved for Type 2 diabetes. People taking Ozempic for diabetes can lose weight as a side effect. But it’s not approved for this purpose.
If you’re interested in learning more about Wegovy or Ozempic, talk to your healthcare team. They can determine if either medication is right for you.
Davies, M., et al. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and Type 2 diabetes (STEP 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet.
Novo Nordisk. (2024). Wegovy (semaglutide) injection, for subcutaneous use [package insert].
Novo Nordisk. (2025). Ozempic (semaglutide) injection, for subcutaneous use [package insert].
NovoCare. (n.d.). NovoCare pharmacy.
Rubino, D., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA.
Weghuber, D., et al. (2022). Once-weekly semaglutide in adolescents with obesity. The New England Journal of Medicine.
Wharton, S., et al. (2021). Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes, Obesity and Metabolism.
Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine.